KPV vs Melanotan II
Emerging vs Well Studied
monitor Researched · 90% Both are α-MSH related; KPV lacks pigmentation effects but monitor for cumulative effects.
Molecular Data
KPV Melanotan II
Half-life 1-2 hours ~2 hours
Chain 3 amino acids —
Type Tripeptide Synthetic alpha-MSH analog
Key Benefits
KPV
01 Systemic anti-inflammatory effects
02 No pigmentation/tanning effects
03 Immune modulation without immunosuppression
04 Potential for autoimmune conditions
05 Gut health support
06 Multiple delivery routes available
Melanotan II
01 Rapid tanning without UV exposure
02 Enhanced sexual function and libido
03 Appetite suppression
04 Improved mood via melanocortin activation
05 Photoprotection through increased melanin
Dosing Protocols
KPV
200-500 mcg per injection / 1-2 times daily (once for maintenance, twice for active inflammation)
General anti-inflammatory 200-300mcg Once daily
Active inflammation 250mcg Twice daily
Autoimmune support 500mcg Once daily
Acute flare-ups 500mcg 2x daily for 1 week, then reduce
Melanotan II
Loading: Start 0.25mg daily, increase to 0.5-1mg; Maintenance: 0.5-1mg 2-3x weekly / Loading phase: Daily for first week, then tanning maintenance 2-3x weekly or as needed for sexual enhancement
Initial loading phase 0.25mg 1x daily
Tanning maintenance 0.5-1mg 2-3x weekly
Sexual enhancement 0.5-1mg As needed
Minimal side effects 0.1-0.25mg Every other day
Photoprotection 0.5mg 2x weekly
Side Effects
KPV
Minimal to no side effects reported
Does not cause immunosuppression like steroids
No melanin production/tanning effects
May temporarily reduce inflammation-related symptoms
Melanotan II
Nausea (pre-treatment with antiemetics recommended)
Facial flushing
Temporary blood pressure elevation
Fatigue
Spontaneous erections
Contraindications
Known peptide allergies
Active severe infections (theoretical)
Pregnancy or breastfeeding (limited data)
History of melanoma or dysplastic nevi
Pregnancy or breastfeeding
Cardiovascular conditions
Uncontrolled hypertension
Research Evidence
KPV Melanotan II
Status Emerging Well Studied
References 5 studies 4 studies
Latest December 2024 2024
FDA Approved No No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.